Find clinical trials for Melanoma in Budapest, Budapest

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer

Carcinoma

Squamous Cell Carcinoma of Head and Neck

Non-Small-Cell Lung Carcinoma

Renal Cell Carcinoma

Lung Cancer

Squamous Cell Carcinoma

Melanoma trials near Budapest, Budapest, HUN:

A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma

binimetinib, and pembrolizumab) given together for the treatment of melanoma that:* is advanced or metastatic (spread to other parts of the ...

Active, not recruiting

Melanoma

Drug: Binimetinib

Drug: Encorafenib

Phase 3

Pfizer

Budapest, Hungary and 227 other locations

Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation. (COLUMBUS-AD)

the efficacy and safety of 12 months of encorafenib in combination with binimetinib in adjuvant setting of BRAF V600E/K mutant stage IIB/C melanoma...

Active, not recruiting

Melanoma

Drug: Placebo to match Encorafenib ; Placebo to match Binimetinib

Drug: Encorafenib and Binimetinib

Phase 3

Pierre Fabre

Budapest, Hungary and 154 other locations

IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)

with previously untreated unresectable or metastatic (advanced) melanoma.Patients will be stratified on the basis of the following factors; ...

Active, not recruiting

Unresectable Melanoma

Metastatic Melanoma

Drug: Pembrolizumab

Drug: IO102-IO103

Phase 3

IO Biotech

Budapest, Hungary and 111 other locations

Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma (CheckMate 238)

The purpose of this study is to determine whether nivolumab is better than ipilimumab to prevent recurrence of melanoma....

Active, not recruiting

Melanoma

Drug: Ipilimumab

Drug: Nivolumab

Phase 3

Bristol-Myers Squibb (BMS)

Budapest, Hungary and 135 other locations

Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma (COLUMBUS)

in patients with locally advanced unresectable or metastatic melanoma with BRAF V600 mutation. A total of approximately 900 patients will be...

Active, not recruiting

Melanoma

Drug: LGX818

Drug: vemurafenib

Phase 3

Pfizer

Budapest, Hungary and 396 other locations

Dabrafenib and/or Trametinib Rollover Study

This study is to provide access for patients who are receiving treatment with dabrafenib and/or trametinib in a Novartis-sponsored Oncology Global De...

Enrolling

Melanoma

Solid Tumor

Drug: dabrafenib

Drug: trametinib

Phase 4

Novartis

Budapest, Hungary and 26 other locations

Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.

cell, pancreatic and biliary duct, endometrial, melanoma and urothelial tumors. This study contains two parts, single agent dose escalation...

Active, not recruiting

Melanoma Cancer

Endometrial Cancer

Drug: PF-06940434

Drug: PF-06801591

Phase 1

Pfizer

Komárno, Slovakia and 40 other locations

A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive

This study is being conducted to determine the safety, tolerability, and preliminary efficacy of INCB099280 in participants with advanced solid tumor...

Active, not recruiting

Advanced Solid Tumor

Drug: INCB099280

Phase 2

Incyte

Budapest, Hungary and 55 other locations

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

The study is a prospective, randomized controlled phase III trial, to test the efficacy, safety and neurocognitive outcomes of advanced NSCLC patient...

Active, not recruiting

Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

Other: Best Standard of Care

Device: NovoTTF-200M device

Phase 3

NovoCure

Budapest, Hungary and 127 other locations

Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)

Brief Summary:The study is a prospective, randomized controlled phase III trial aimed to test the efficacy and safety of Tumor Treating Fields (TTFie...

Active, not recruiting

Pancreas Adenocarcinoma

Drug: nab paclitaxel

Drug: Gemcitabine

Phase 3

NovoCure

Budapest, Hungary and 197 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Melanoma in .css-epvm6{white-space:nowrap;}Budapest, Budapest

Related conditions:

Melanoma trials near Budapest, Budapest, HUN:

A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma

Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation. (COLUMBUS-AD)

IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)

Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma (CheckMate 238)

Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma (COLUMBUS)

Dabrafenib and/or Trametinib Rollover Study

Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.

A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)

Find clinical trials for Melanoma in Budapest, Budapest